FDA revoked authorization of use of the emergencia para tratamiento experimental and patients of COVID-19
The Food and Drug Administration (FDA, by its seal in English) of the EE.UU. revoked the emergency use authorization which allows the experimental therapy of bamlanivimab monoclonal anticoagulants,…
